Analysis of models of doxorubicin-induced cardiomyopathy in rats and mice. A modern view from the perspective of the pathophysiologist and the clinician

EY Podyacheva, EA Kushnareva, AA Karpov… - Frontiers in …, 2021 - frontiersin.org
Today the pharmacological possibilities of treating cancer are expanding and as a result, life
expectancy is increasing against the background of chemotherapy and supportive treatment …

[HTML][HTML] Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy

Y Chen, S Shi, Y Dai - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Doxorubicin (DOX), as a kind of chemotherapy agent with remarkable therapeutic effect, can
be used to treat diverse malignant tumors clinically. Dose-dependent cardiotoxicity is the …

Cardioprotective effects of alpha‐mangostin on doxorubicin‐induced cardiotoxicity in rats

F Eisvand, M Imenshahidi… - Phytotherapy …, 2022 - Wiley Online Library
The main adverse effect of doxorubicin is cardiotoxicity. Oxidative stress and apoptosis
induction have been suggested as mechanisms involved in its cardiotoxicity. In this study …

Does DPP-IV inhibition offer new avenues for therapeutic intervention in malignant disease?

P Busek, JS Duke-Cohan, A Sedo - Cancers, 2022 - mdpi.com
Simple Summary There is growing interest in identifying the effects of antidiabetic agents on
cancer risk, progression, and anti-cancer treatment due to the long-term use of these …

SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity

E Podyacheva, Y Toropova - Frontiers in Pharmacology, 2022 - frontiersin.org
According to the World Health Organization, the neoplasm is one of the main reasons for
morbidity and mortality worldwide. At the same time, application of cytostatic drugs like an …

Combined diosmin and bisoprolol attenuate cobalt chloride-induced cardiotoxicity and endothelial dysfunction through modulating miR-143-3P/MAPK/MCP-1, ERK5 …

EAM El-Shoura, AAN Mohamed, AM Atwa… - International …, 2024 - Elsevier
Even while accelerated cardiomyocyte apoptosis is one of the primary causes of cardiac
damage, the underlying mechanism is still mostly unknown. In addition to examining …

Cardioprotective effect of chelidonic acid against doxorubicin-induced cardiac toxicity in rats

SI Khairnar, YA Kulkarni, K Singh - Revista Portuguesa de Cardiologia, 2024 - Elsevier
Introduction and objectives The current study evaluates the effect of chelidonic acid on
doxorubicin-induced cardiac toxicity. Chelidonic acid (CA) is a natural pyran-skeleton …

[HTML][HTML] Modeling doxorubicin-induced cardiomyopathy with fibrotic myocardial damage in wistar rats

E Podyacheva, T Shmakova, E Kushnareva… - Cardiology …, 2022 - ncbi.nlm.nih.gov
Background Cardiovascular complications, arising after anthracycline chemotherapy, cause
a significant deterioration in the life quality and expectancy of those patients who were …

Research progress on activation transcription factor 3: A promising cardioprotective molecule

H Ke, Z Chen, X Zhao, C Yang, T Luo, W Ou, L Wang… - Life Sciences, 2023 - Elsevier
Abstract Activation transcription factor 3 (ATF3), a member of the ATF/cyclic adenosine
monophosphate response element binding family, can be induced by a variety of stresses …

Anti-Diabetic Therapies and Cancer: From Bench to Bedside

D Kounatidis, NG Vallianou, I Karampela, E Rebelos… - Biomolecules, 2024 - mdpi.com
Diabetes mellitus (DM) is a significant risk factor for various cancers, with the impact of anti-
diabetic therapies on cancer progression differing across malignancies. Among these …